Insulin and disorders of behavioural flexibility
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved..
Behavioural inflexibility is a symptom of neuropsychiatric and neurodegenerative disorders such as Obsessive-Compulsive Disorder, Autism Spectrum Disorder and Alzheimer's Disease, encompassing the maintenance of a behaviour even when no longer appropriate. Recent evidence suggests that insulin signalling has roles apart from its regulation of peripheral metabolism and mediates behaviourally-relevant central nervous system (CNS) functions including behavioural flexibility. Indeed, insulin resistance is reported to generate anxious, perseverative phenotypes in animal models, with the Type 2 diabetes medication metformin proving to be beneficial for disorders including Alzheimer's Disease. Structural and functional neuroimaging studies of Type 2 diabetes patients have highlighted aberrant connectivity in regions governing salience detection, attention, inhibition and memory. As currently available therapeutic strategies feature high rates of resistance, there is an urgent need to better understand the complex aetiology of behaviour and develop improved therapeutics. In this review, we explore the circuitry underlying behavioural flexibility, changes in Type 2 diabetes, the role of insulin in CNS outcomes and mechanisms of insulin involvement across disorders of behavioural inflexibility.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:150 |
---|---|
Enthalten in: |
Neuroscience and biobehavioral reviews - 150(2023) vom: 01. Juli, Seite 105169 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sullivan, Mairéad [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 05.06.2023 Date Revised 05.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.neubiorev.2023.105169 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355635550 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM355635550 | ||
003 | DE-627 | ||
005 | 20231226064748.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.neubiorev.2023.105169 |2 doi | |
028 | 5 | 2 | |a pubmed24n1185.xml |
035 | |a (DE-627)NLM355635550 | ||
035 | |a (NLM)37059405 | ||
035 | |a (PII)S0149-7634(23)00138-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sullivan, Mairéad |e verfasserin |4 aut | |
245 | 1 | 0 | |a Insulin and disorders of behavioural flexibility |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.06.2023 | ||
500 | |a Date Revised 05.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a Behavioural inflexibility is a symptom of neuropsychiatric and neurodegenerative disorders such as Obsessive-Compulsive Disorder, Autism Spectrum Disorder and Alzheimer's Disease, encompassing the maintenance of a behaviour even when no longer appropriate. Recent evidence suggests that insulin signalling has roles apart from its regulation of peripheral metabolism and mediates behaviourally-relevant central nervous system (CNS) functions including behavioural flexibility. Indeed, insulin resistance is reported to generate anxious, perseverative phenotypes in animal models, with the Type 2 diabetes medication metformin proving to be beneficial for disorders including Alzheimer's Disease. Structural and functional neuroimaging studies of Type 2 diabetes patients have highlighted aberrant connectivity in regions governing salience detection, attention, inhibition and memory. As currently available therapeutic strategies feature high rates of resistance, there is an urgent need to better understand the complex aetiology of behaviour and develop improved therapeutics. In this review, we explore the circuitry underlying behavioural flexibility, changes in Type 2 diabetes, the role of insulin in CNS outcomes and mechanisms of insulin involvement across disorders of behavioural inflexibility | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Addiction | |
650 | 4 | |a Alzheimer’s disease | |
650 | 4 | |a Anorexia Nervosa | |
650 | 4 | |a Autism spectrum disorder | |
650 | 4 | |a IGF1 | |
650 | 4 | |a Insulin | |
650 | 4 | |a Metformin | |
650 | 4 | |a Neuropsychiatric disorders | |
650 | 4 | |a Obesity | |
650 | 4 | |a Obsessive-compulsive disorder | |
650 | 4 | |a Parkinson’s disease | |
650 | 4 | |a Type 2 diabetes | |
650 | 7 | |a Insulin |2 NLM | |
700 | 1 | |a Fernandez-Aranda, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Camacho-Barcia, Lucía |e verfasserin |4 aut | |
700 | 1 | |a Harkin, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Macrì, Simone |e verfasserin |4 aut | |
700 | 1 | |a Mora-Maltas, Bernat |e verfasserin |4 aut | |
700 | 1 | |a Jiménez-Murcia, Susana |e verfasserin |4 aut | |
700 | 1 | |a O'Leary, Aet |e verfasserin |4 aut | |
700 | 1 | |a Ottomana, Angela Maria |e verfasserin |4 aut | |
700 | 1 | |a Presta, Martina |e verfasserin |4 aut | |
700 | 1 | |a Slattery, David |e verfasserin |4 aut | |
700 | 1 | |a Scholtz, Samantha |e verfasserin |4 aut | |
700 | 1 | |a Glennon, Jeffrey C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neuroscience and biobehavioral reviews |d 1982 |g 150(2023) vom: 01. Juli, Seite 105169 |w (DE-627)NLM000456977 |x 1873-7528 |7 nnns |
773 | 1 | 8 | |g volume:150 |g year:2023 |g day:01 |g month:07 |g pages:105169 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neubiorev.2023.105169 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 150 |j 2023 |b 01 |c 07 |h 105169 |